Affordable Access

Publisher Website

Clinical efficacy of ciprofloxacin in long-term therapy for chronic respiratory tract infections

Authors
Journal
Current Therapeutic Research
0011-393X
Publisher
Elsevier
Publication Date
Volume
52
Issue
2
Identifiers
DOI: 10.1016/s0011-393x(05)80481-3

Abstract

Abstract The clinical efficacy of ciprofloxacin was evaluated in 83 patients with chronic respiratory tract infection. Each patient received ciprofloxacin 200 mg TID for 2 or 4 weeks. After 2 weeks of treatment for acute exacerbation of chronic respiratory tract infection, 21 (52.5%) of 40 evaluable patients were considered “improved.” After 4 weeks of treatment, 24 (75%) of 32 evaluable patients were judged “improved.” An additional 2 weeks of treatment increased the rate of improvement. On the other hand, only 6 (23.1%) and 7 (26.9%) of 26 evaluable patients were considered “improved” after 2 and 4 weeks of treatment, respectively, for chronic inflammation. Ciprofloxacin was also administered to 6 patients for more than 60 days to examine its prophylactic effect against acute exacerbation. No patient had an acute exacerbation within 60 days of treatment. Ciprofloxacin is a useful oral antibacterial agent for the treatment and prophylaxis of acute exacerbation of chronic respiratory tract infection.

There are no comments yet on this publication. Be the first to share your thoughts.